Applied Genetic Technologies (NASDAQ: AGTC) reported Q2 EPS of ($0.23), $0.45 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $2.64 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.